Germany: BioNTech shutting down COVID vaccine production entirely, 1,860 jobs at risk
🤖AI Özeti
BioNTech, the German company known for developing one of the first mRNA COVID-19 vaccines, is ceasing its vaccine production and transferring responsibilities to its partner, Pfizer. This decision comes as BioNTech shifts its focus towards research in other areas, particularly cancer. The move puts approximately 1,860 jobs at risk, raising concerns about the impact on employees and the future of vaccine development.
💡AI Analizi
📚Bağlam ve Tarihsel Perspektif
BioNTech gained prominence during the COVID-19 pandemic for its role in developing one of the first effective vaccines in collaboration with Pfizer. As the pandemic situation evolves and vaccination rates stabilize, companies are reassessing their strategies and resource allocations, leading to significant changes in operations.
This article is based on information available at the time of publication and may be subject to change.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü Gör
NewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.